Thomas Flaten's Stock Ratings

Lake Street Analyst

Thomas Flaten is an analyst at Lake Street. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-17.1%

Smart Score

37.3%

Overall Average Return Percentile

13th

Number of Ratings

29
Buy NowGet Alert
05/15/2024OPTNBuy Now
OptiNose
$1.14163.16%$4 → $3MaintainsBuyGet Alert
04/30/2024PSNLBuy Now
Personalis
$1.47172.13% → $4Initiates → BuyGet Alert
04/19/2024DMTKBuy Now
DermTech
$0.3866.01% → $0.63DowngradeBuy → HoldGet Alert
03/18/2024OPTNBuy Now
OptiNose
$1.14250.88%$3 → $4MaintainsBuyGet Alert
03/12/2024ASRTBuy Now
Assertio Holdings
$1.07180.37%$4 → $3MaintainsBuyGet Alert
03/07/2024AQSTBuy Now
Aquestive Therapeutics
$3.15153.57%$3 → $8MaintainsBuyGet Alert
03/05/2024ACHVBuy Now
Achieve Life Sciences
$5.15113.59%$19 → $11MaintainsBuyGet Alert
08/21/2023OPTNBuy Now
OptiNose
$1.14163.16% → $3Initiates → BuyGet Alert
08/16/2023CKPTBuy Now
Checkpoint Therapeutics
$2.03589.66%$16 → $14MaintainsBuyGet Alert
08/10/2023BTTXBuy Now
Better Therapeutics
$0.0124796.27%$5 → $3MaintainsBuyGet Alert
08/09/2023BLFSBuy Now
BioLife Solns
$21.8314.52%$34 → $25MaintainsBuyGet Alert
07/07/2023CSTLBuy Now
Castle Biosciences
$24.5530.35% → $32ReiteratesBuy → BuyGet Alert
06/05/2023CSTLBuy Now
Castle Biosciences
$24.5530.35%$41 → $32MaintainsBuyGet Alert
05/31/2023ACHVBuy Now
Achieve Life Sciences
$5.15268.93%$22 → $19MaintainsBuyGet Alert
05/30/2023CKPTBuy Now
Checkpoint Therapeutics
$2.03688.18%$22 → $16MaintainsBuyGet Alert
05/10/2023ACHVBuy Now
Achieve Life Sciences
$5.15327.18% → $22MaintainsBuyGet Alert
05/10/2023ASRTBuy Now
Assertio Holdings
$1.07741.12%$8 → $9MaintainsBuyGet Alert
04/14/2023BTTXBuy Now
Better Therapeutics
$0.0141393.78%$6 → $5MaintainsBuyGet Alert
04/04/2023CKPTBuy Now
Checkpoint Therapeutics
$2.03983.74%$32 → $22MaintainsBuyGet Alert
03/31/2023EVAXBuy Now
Evaxion Biotech
$3.8780.88%$180 → $70MaintainsBuyGet Alert
12/01/2022OCXBuy Now
OncoCyte
$2.76-81.88%$60 → $10DowngradeBuy → HoldGet Alert
11/17/2022ENSCBuy Now
Ensysce Biosciences
$0.74984.3%$960 → $96MaintainsBuyGet Alert
11/07/2022ASRTBuy Now
Assertio Holdings
$1.07554.21% → $7Initiates → BuyGet Alert
08/11/2022OCXBuy Now
OncoCyte
$2.768.7%$120 → $60MaintainsBuyGet Alert
07/07/2022DMACBuy Now
DiaMedica Therapeutics
$3.35138.81%$14 → $8MaintainsBuyGet Alert
05/13/2022BBIBuy Now
Brickell Biotech
DowngradeBuy → HoldGet Alert
03/11/2022OCXBuy Now
OncoCyte
$2.76117.39%$220 → $120MaintainsBuyGet Alert
03/01/2022CSTLBuy Now
Castle Biosciences
$24.55156.62%$94 → $63MaintainsBuyGet Alert
11/30/2021ENSCBuy Now
Ensysce Biosciences
$0.74442.15%Initiates → BuyGet Alert